newsfilter
← Latest News
Business Wire·

Cortexyme Announces Agreement to Acquire Novosteo

Expanding pipeline with addition of targeted therapeutics to treat rare skeletal diseases, bone cancer and injury Strengthening leadership team with appointment of Novosteo executives Dr. Dirk Thye as CEO and Dr. Karen Smith as CMO of combined compan